We present a case of resuscitation of a 38-year-old lady with ventricular fibrillation using the Lund University Cardiopulmonary Assist System (LUCAS), a mechanical cardiopulmonary resuscitation (CPR) device. Return of spontaneous circulation was obtained after prolonged resuscitation but the patient eventually succumbed nine days after admission to the coronary care unit. The role of mechanical CPR devices in resuscitation in the accident and emergency department is discussed. (Hong Kong j.emerg.med. 2008;15:49-52) 38 LUCAS 9
An unconscious 38-year-old lady was admitted to our Accident & Emergency Department (AED) in October 2007. She was the mother of a student at a school. She was attending the parents' day when she was noted by school staff to be breathless. According to the ambulance staff, she collapsed shortly at 10:33 am and prompt bystander cardiopulmonary resuscitation (CPR) was started. Ventricular fibrillation (VF) was detected by the automatic external defibrillator and three shocks were given in the ambulance.
The patient was in VF on arrival at the AED. We had been using the Lund University Cardiopulmonary Assist System (LUCAS), a mechanical CPR device during resuscitations in our department since August 2007 ( Figure 1 ). The LUCAS was promptly applied at 10:47 am, 14 minutes after the collapse to commence m e c h a n i c a l c h e s t c o m p r e s s i o n a n d a c t i v e decompression. Resuscitation had been vigorous for this young lady who had a short arrest interval. She was intubated and mechanical ventilation was started. Amiodarone 300 mg bolus followed by 150 mg twice was given. Adrenaline 1 mg intravenously every 3 minutes was also administered. Magnesium 2 g intravenously was administered 28 minutes after the start of resuscitation in the AED. The end-tidal CO 2 had all along been low at 5 mmHg with no return of circulation. She was given multiple biphasic defibrillations at 200J for persistent VF.
Subsequently, restoration of spontaneous circulation was achieved 48 minutes after the start of CPR in the AED. There was a good radial pulse and the first blood pressure was 118/60 mmHg and pulse rate was 80 per minute. The end-tidal CO 2 was 45 mmHg. The medical department was consulted and the patient was admitted to the coronary care unit (CCU) for further management.
In the CCU, the patient remained in a comatose state with recurrent ventricular fibrillation. She was treated w i t h d o p a m i n e a n d a m i o d a r o n e i n f u s i o n . Subsequently, the VF was terminated by overdrive pacing. Therapeutic hypothermia was given for 24 hours but with no improvement. The ECG in the CCU revealed downsloping ST segments from V1 to V3 suggesting the Brugada syndrome ( Figure 2 ). The patient eventually succumbed nine days after admission to the CCU. The patient's children were referred to the paediatric department for cardiac screening of the Brugada syndrome. 
Discussion
The Brugada syndrome is one of the causes of sudden death in young patients. In 10-30% of cases a mutation in the gene SCN5A, encoding the cardiac voltage-gated sodium channel Na v 1.5, has been found. Sudden onset of fatal ventricular tachyarrhythmia can occur. The diagnosis is made by noting coved or saddle-shaped ST elevation in medial chest leads in the ECG. Occasionally, this is associated with partial or complete right bundle branch block. The definitive treatment is implantation of internal cardioverter defibrillator. 1 The provision of uninterrupted, high quality chest compression was emphasized in the 2005 Advanced Cardiac Life Support (ACLS) guidelines. Rescuers should 'push hard, push fast' at a rate of 100 compressions per minute at a depth of 1.5 to 2 inches for adult patients. The chest should be allowed to recoil completely. 2 Studies using manikins showed that the quality of chest compression would start to deteriorate over 90 seconds. 3 Compressions would become too shallow or slow and there might be frequent hands-off periods when no effective circulation was produced. Even with correctly executed manual CPR, only around 20% of normal cardiac output was produced which would further be jeopardised by human fatigue. Mechanical CPR devices have been developed to provide continuous and consistent chest compressions in resuscitation.
At present, there is no evidence that the use of mechanical CPR devices improves survival to hospital discharge with intact neurological status. However, there are animal and human studies showing that mechanical CPR improves haemodynamics during resuscitation and the short term survival to hospital admission. 4 The LUCAS (JOLIFE AB, Lund, Sweden) was used in resuscitating this young lady. It is an air driven portable mechanical CPR device. It can be connected to wall or cylinder gas inlets. It consists of a silicon rubber suction cup and a pneumatic cylinder. The cylinder is mounted on two legs which are connected to a back plate where the patient rests on. It gives continuous compression and active decompression at a rate of 100 per minute. The maximum depth of chest compression is 2 inches.
Steen et al showed that LUCAS CPR increased aortic, right atrial and coronary perfusion pressure in pigs during induced VF when compared to manual CPR. 5 Rubertsson et al reported improved cerebral blood flow using a laser-Doppler flow probe during LUCAS CPR for induced VF in pigs. 6 In his study of 100 out-of-hospital cardiac arrest patients receiving LUCAS CPR, Steen et al reported a survival rate of 25% after 30 days with good neurological status for patients with: 1. witnessed cardiac arrest 2. bystander CPR 3. VF being the presenting rhythm 4. LUCAS applied within 15 minutes after the call for ambulance 5. therapeutic hypothermia applied on hospital arrival On the other hand, for all unwitnessed cardiac arrest cases and patients where the LUCAS was applied more than 15 minutes after the call for ambulance, no 30-day survivor was noted. Steen suggested that for patients with witnessed cardiac arrest where stable return of spontaneous circulation (ROSC) could not be obtained, transport should be made under mechanical CPR to a hospital where revascularisation service was available. 7 For our patient, the LUCAS was applied 14 minutes after witnessed cardiac arrest. The poor prognosis was therefore not unexpected.
Autopulse (Revivant Corporation, Sunnyvale, CA) is another mechanical CPR device that has been approved for use by the Food and Drug Administration. In Autopulse, a load distributing band, analogous to a large blood pressure cuff, is wrapped around the patient's chest. The band is controlled by a rotating motor so that cyclical compressions are applied to the anterior and anterolateral parts of the chest wall. Timerman et al reported that the Autopulse increased peak aortic pressure, right atrial pressure and coronary perfusion pressure when compared to manual CPR during the treatment of in-hospital cardiac arrest patients. 8 A prehospital study conducted in Richmond, Virginia utilising historical controls found improved outcomes including survival to hospital discharge in patients with sudden cardiac arrest treated with the Autopulse. 9 However, the Autopulse Prehospital International Resuscitation (ASPIRE) trial, a multicentre, cluster randomised study testing the effectiveness of the Autopulse against standard CPR, was terminated early due to a decrease in survival to hospital discharge at some study sites. 10 The discrepancies between these two studies were attributed to differences in patient populations, training, monitoring and methodology. Large scale, well designed randomised control trials are therefore essential in evaluating the impact of mechanical CPR devices in resuscitations.
Mechanical CPR devices should be promptly applied to improve the outcome during resuscitation. To shorten the application interval, mechanical CPR d e v i c e s h a ve b e e n u s e d d u r i n g p re h o s p i t a l resuscitations. Both Autopulse and LUCAS are portable and can be carried in backpacks by ambulance staff. They can be applied to patients at scene soon after cardiac arrest. Mechanical chest compression can be continued during transfer from the patients' home to the ambulance. Ambulance staff may also find it useful as they can sit down and monitor the ongoing mechanical CPR in the ambulance. This is important as good manual CPR is difficult in the moving vehicle.
Mechanical CPR device is a great help for prolonged CPR. It does not relieve us from the difficult decision of when to terminate the resuscitation effort. This can be a difficult task for the emergency physician especially for previously young and healthy patients who are 'too good to die'. According to the 2005 ACLS guidelines, 'a patient should be given a reasonable trial of CPR and ACLS provided that the patient has not expressed a decision to forego resuscitative efforts. The final decision to stop efforts can never be as simple as an isolated time interval.' 11 For this case, we had endeavoured to inform the relatives the grave prognosis and the poor neurological recovery throughout the resuscitation and after ROSC, prior to the CCU admission.
